The Bulletin
The Times


.

Sanyou Bio Secures Exclusive Series C Investment from Zero2IPO Industry Investment, Bringing Total Funding to Nearly RMB 300 Million

  • Written by PR Newswire

Accelerating the Development of an AI-Driven Ecosystem for Innovative Drug R&D and Translation

SHANGHAI, Nov. 9, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") recently announced the completion of a Series C financing round worth nearly RMB 100 million. The round was exclusively funded by Zero2IPO Industry Investment, a...

hacklink esim balkanzlibraryzlibraryz-libraryFanatikbettaraftariumjojobethacklink panelmarsbahisvsf watchesJojobetuk casinos not on gamstopGamStopbahis casino siteleri